2021年5月19日(水) 14:15 〜 16:15 第4会場 (国立京都国際会館 2F Room A)

Chair：Takahiko Tokuda (Department of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Japan),Hanakawa Takashi(Department of Integrated Neuroanatomy and Neuroimaging, Kyoto Univesity Graduate School of Medicine)

This symposium is focused on parallel and synergistic evolutions of diverse imaging modalities and biofluid analyses towards the establishment of biomarkers for Alzheimer’s and Parkinson’s diseases and allied neurodegenerative disorders. Recent advances of PET and MRI technologies have allowed diagnostic and therapeutic evaluations of brain functions and pathologies as a clinical workup, while measurements of disease-associated molecules in blood and CSF potentially offer cost-effective tests for mass screening of elderly populations. Moreover, different imaging modalities, along with neurophysiological examinations, play complementary roles in the clinical assessment of these illnesses, conjunctively covering multiple aspects of the neurofunctional and neuropathological phenotypes. The session is accordingly aimed to exchange scientific information on how the coevolution of distinct imaging and other assaying modalities could be made for the construction of next-generation diagnostic workflows.